Children and adolescents with neurofibromatosis 1: a behavioral phenotype
- PMID: 8856518
Children and adolescents with neurofibromatosis 1: a behavioral phenotype
Abstract
Twenty 6- to 17-year-old children with neurofibromatosis 1. (NF1) were compared to 20 age- and sex-matched siblings on a wide range of neuropsychological and behavioral dimensions. In familial cases, diagnostic status was confirmed by gene linkage with greater than 98% accuracy. Visual examinations that included assessments of visual evoked responses (VER) were performed on subjects with NF1. Forty-two percent of NF1 subjects had abnormal VER and underwent magnetic resonance imagery or computed tomography scans of the brain. On a variety of skills, subjects with NF1 performed more poorly than unaffected siblings. Children with NF1 were found to be less competent on measures of cognitive, language, and motor development, visual-spatial judgment, visual-motor integration, and academic achievement. Learning disabilities were common in children with NF1. Parents and teachers reported that NF1 subjects had internalizing problems and difficulty interacting with peers. A behavioral phenotype for NF1 and recommendations for preventative interventions are proposed.
Similar articles
-
The nature and frequency of cognitive deficits in children with neurofibromatosis type 1.Neurology. 2005 Oct 11;65(7):1037-44. doi: 10.1212/01.wnl.0000179303.72345.ce. Neurology. 2005. PMID: 16217056
-
Behavioural, academic and neuropsychological profile of normally gifted Neurofibromatosis type 1 children.J Intellect Disabil Res. 2005 Jan;49(Pt 1):33-46. doi: 10.1111/j.1365-2788.2005.00660.x. J Intellect Disabil Res. 2005. PMID: 15634310
-
The self-concept of children and adolescents with neurofibromatosis type 1.Child Care Health Dev. 2007 Jul;33(4):401-8. doi: 10.1111/j.1365-2214.2006.00717.x. Child Care Health Dev. 2007. PMID: 17584395
-
Behavioural and cognitive phenotypes in children with neurofibromatosis type 1 (NF1): the link with the neurobiological level.Brain Dev. 2011 Jan;33(1):52-61. doi: 10.1016/j.braindev.2009.12.008. Epub 2010 Jan 27. Brain Dev. 2011. PMID: 20106617 Review.
-
Neurofibromatosis type 1.Genet Couns. 1994;5(3):225-41. Genet Couns. 1994. PMID: 7811422 Review.
Cited by
-
Neuronal NF1/RAS regulation of cyclic AMP requires atypical PKC activation.Hum Mol Genet. 2014 Dec 20;23(25):6712-21. doi: 10.1093/hmg/ddu389. Epub 2014 Jul 28. Hum Mol Genet. 2014. PMID: 25070947 Free PMC article.
-
The effect of methylphenidate on neurofibromatosis type 1: a randomised, double-blind, placebo-controlled, crossover trial.Orphanet J Rare Dis. 2014 Sep 10;9:142. doi: 10.1186/s13023-014-0142-4. Orphanet J Rare Dis. 2014. PMID: 25205361 Free PMC article. Clinical Trial.
-
Skeletal muscle and motor deficits in Neurofibromatosis Type 1.J Musculoskelet Neuronal Interact. 2015 Jun;15(2):161-70. J Musculoskelet Neuronal Interact. 2015. PMID: 26032208 Free PMC article. Review.
-
Brief Report: The Prevalence of Neurofibromatosis Type 1 among Children with Autism Spectrum Disorder Identified by the Autism and Developmental Disabilities Monitoring Network.J Autism Dev Disord. 2016 Oct;46(10):3369-76. doi: 10.1007/s10803-016-2877-3. J Autism Dev Disord. 2016. PMID: 27465244 Free PMC article.
-
Social Function and Autism Spectrum Disorder in Children and Adults with Neurofibromatosis Type 1: a Systematic Review and Meta-Analysis.Neuropsychol Rev. 2018 Sep;28(3):317-340. doi: 10.1007/s11065-018-9380-x. Epub 2018 Aug 11. Neuropsychol Rev. 2018. PMID: 30097761
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous